| PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data PN Aguiar Jr, RA De Mello, P Hall, H Tadokoro, G Lima Lopes Immunotherapy 9 (6), 499-506, 2017 | 196 | 2017 |
| DNA hypermethylation within TERT promoter upregulates TERT expression in cancer DD Lee, R Leao, M Komosa, M Gallo, CH Zhang, T Lipman, M Remke, ... The Journal of clinical investigation 129 (1), 223-229, 2019 | 182 | 2019 |
| The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis PN Aguiar Jr, IL Santoro, H Tadokoro, G de Lima Lopes, BA Filardi, ... Immunotherapy 8 (4), 479-488, 2016 | 169 | 2016 |
| The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC PN Aguiar Jr, LA Perry, J Penny-Dimri, H Babiker, H Tadokoro, ... Annals of Oncology 28 (9), 2256-2263, 2017 | 101 | 2017 |
| MicroRNAs in lung cancer D Castro, M Moreira, AM Gouveia, DH Pozza, RA De Mello Oncotarget 8 (46), 81679, 2017 | 98 | 2017 |
| Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies RA de Mello, DS Marques, R Medeiros, AMF Araújo World Journal of Clinical Oncology 2 (11), 367, 2011 | 74 | 2011 |
| Potential role of immunotherapy in advanced non-small-cell lung cancer RA De Mello, AF Veloso, P Esrom Catarina, S Nadine, G Antoniou OncoTargets and therapy, 21-30, 2016 | 68 | 2016 |
| Immunotherapy and lung cancer: current developments and novel targeted therapies D Domingues, A Turner, MD Silva, DS Marques, JC Mellidez, ... Immunotherapy 6 (11), 1221-1235, 2014 | 67 | 2014 |
| HER2 therapies and gastric cancer: a step forward RA de Mello, AM Marques, A Araújo World journal of gastroenterology: WJG 19 (37), 6165, 2013 | 60 | 2013 |
| MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway JH Zhu, RA De Mello, QL Yan, JW Wang, Y Chen, QH Ye, ZJ Wang, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (6), 165747, 2020 | 49 | 2020 |
| EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer RA De Mello, P Madureira, LS Carvalho, A Araujo, M O’Brien, S Popat Pharmacogenomics 14 (14), 1765-1777, 2013 | 48 | 2013 |
| Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution RA De Mello, S Geros, MP Alves, F Moreira, I Avezedo, J Dinis PloS one 9 (2), e86697, 2014 | 47 | 2014 |
| Epigenetic therapy in urologic cancers: an update on clinical trials I Faleiro, R Leão, A Binnie, RA De Mello, AT Maia, P Castelo-Branco Oncotarget 8 (7), 12484, 2017 | 46 | 2017 |
| A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker PN Aguiar Jr, IL Santoro, H Tadokoro, G de Lima Lopes, BA Filardi, ... Immunotherapy 8 (9), 1011-1019, 2016 | 46 | 2016 |
| Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives I Marques, A Araújo, RA de Mello World Journal of Gastroenterology: WJG 19 (44), 7955, 2013 | 42 | 2013 |
| Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies R Andrade de Mello, B M Costa, R M Reis, V Hespanhol Recent patents on anti-cancer drug discovery 7 (1), 118-131, 2012 | 42 | 2012 |
| Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets PN Aguiar Jr, RA De Mello, LA Perry, J Penny-Dimri, H Tadokoro, ... ESMO open 2 (3), e000200, 2017 | 41 | 2017 |
| Lung cancer: a brief review of epidemiology and screening C Gouvinhas, RA De Mello, D Oliveira, JM Castro-Lopes, ... Future Oncology 14 (6), 567-575, 2018 | 40 | 2018 |
| New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives RA De Mello, NM Neves, H Tadokoro, GA Amaral, P Castelo-Branco, ... Journal of clinical medicine 9 (11), 3543, 2020 | 39 | 2020 |
| Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies M Luis, A Tavares, LS Carvalho, L Lara-Santos, A Araújo, RA de Mello World Journal of Gastroenterology: WJG 19 (38), 6383, 2013 | 37 | 2013 |
